Metabolomics Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis

MARKET OVERVIEW

Metabolomics is the study of small molecules which resides in cells, biofluids, and tissues. The studies are extensively conducted with an aim to analyze biochemical activities of these small molecules and their interactions with biological systems. Metabolomics has wide variety of applications in disease diagnosis, drug discovery, enzyme discovery, and others.

MARKET SCOPE

The "Global Metabolomics Market Analysis to 2031" is a specialized and in-depth study of the biotechnology industry with a special focus on the global market trend analysis. The report aims to provide an overview of the metabolomics market with detailed market segmentation by product, application, indication, end user, and geography. The report provides key statistics on the market status of the leading metabolomics market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

•  On the basis of product, the market is segmented into metabolomics instruments, bioinformatics tools and services.
  
•  Based on application, the metabolomics market is classified as biomarker discovery, drug discovery, toxicology testing, nutrigenomics, functional genomics, personalized medicine, others.
  
•  Based on indication, the metabolomics market is classified as cancer, cardiovascular disorders, neurological disorders, metabolic disorders, others.
  
•  Based on end user, the metabolomics market is classified as academic and research institutes, pharmaceutical and biotechnology companies, contract research organizations.
  

MARKET DYNAMICS

Drivers:

•   Increasing Number Of Government Activities To Promote Use Of Metabolomics
  
•   Wide Variety Of Applications Of The Modern Technology In The Field Of Medical Science
  

Restraints:

•   Issues Related To Data Examination And Processing
  

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The metabolomics market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.

The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the marketduring the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the metabolomics market in these regions.

IMPACT OF COVID-19 ON METABOLOMICS MARKET

The COVID-19 pandemic has significantly affected the life sciences instruments market. The analytical instrumentation sector is witnessing challenges in the manufacturing and supply chain, such as delivering products to end users on time and attending to an uneven demand for products and services. Considering the current pandemic and the contribution of the pharma & biotech industry to control the spread of the virus by providing essential drugs, vaccines, kits, and other supplies, the demand for instruments for metabolomics research is expected to increase in the industry in the coming months..

MARKET PLAYERS

The report covers key developments in the cancer antigens market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from metabolomics market are anticipated to lucrative growth opportunities in the future with the rising demand for metabolomics in the global market.

The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the metabolomics market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.

•  Thermo Fisher Scientific Inc.
  
•  Waters Corporation
  
•  Agilent Technologies, Inc.
  
•  Human Metabolome Technologies, Inc.
  
•  Bruker Corporation
  
•  Shimadzu Corporation
  
•  PerkinElmer
  
•  Metabolon, Inc.
  
•  Leco Corporation
  
•  Hitachi High-Technologies Corporation
  
•  GL Sciences
  

The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

Metabolomics Report Scope